News

INmune Bio's XPro shows promise in early AD despite missed endpoints. Click here to find out why I rate INMB stock is a Hold.
Moody’s affirmation of Baa2 at C.H. Robinson holds its rating on the 3PL that has been in place since at least 2018. S&P ...
Earnings diversity and robust capital has led S&P to upgrade its long-term issuer and financial strength ratings on Arch’s ...
Fitch affirmed its BBB- investment-grade credit rating for the U.S. planemaker, pointing to stronger free cash flow prospects ...